Double-blind comparison of antihypertensive treatment with ramipril and piretanide, given alone or in combination

Journal of Cardiovascular Pharmacology

Volumn 26, Issue 1, 1995, Pages 33-38

  Thijs, Lutgarde ^a   Cells, Hilde ^a   Kiowski, Wolfgang ^b   Löffler, Kurt ^c   Middeke, Martin ^d   Schulz, Wolfgang ^c   Staessen, Jan ^a   Amery, Antoon ^a  

^a KU LEUVEN DEPARTMENT OF REHABILITATION SCIENCES   (Belgium)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c SANOFI   (France)

^d Reha Zentrum Spreewald ^*  (Germany)

Author keywords

Combination therapy; Hypertension; Piretanide; Ramipril

Indexed keywords

CREATININE; GLUCOSE; PIRETANIDE; PLACEBO; POTASSIUM; RAMIPRIL; URIC ACID;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DOUBLE BLIND PROCEDURE; FEMALE; HEADACHE; HUMAN; HYPERTENSION; HYPERURICEMIA; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; POLYURIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SOMNOLENCE; TREATMENT OUTCOME; VERTIGO;

ADULT; AGED; ANTIHYPERTENSIVE AGENTS; BLOOD CHEMICAL ANALYSIS; BLOOD PRESSURE; DIURETICS; DOUBLE-BLIND METHOD; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; RAMIPRIL; SINGLE-BLIND METHOD; SULFONAMIDES; TREATMENT OUTCOME;

EID: 0029012182     PISSN: 01602446     EISSN: 15334023     Source Type: Journal    
DOI: 10.1097/00005344-199507000-00006     Document Type: Article

References (30)

1. Collins R. Peto R. MacMahon S. et al. Blood pressure, stroke, and coronary heart disease. Part 2, short-term reductions in blood pressure: Overview of randomized drug trials in their epidemiological context. Lancet 1990;335:827-38.
2. Thijs, L, Fagard R, Lijnen P, Staessen J, Van Hoof R, Amery A. A meta-analysis of outcome trials in elderly hypertensives. J Hypertens 1992;10:1103-9.
3. Middeke M. Holzgreve H. Review of major intervention studies in hypertension and hyperlipidemia: Focus on coronary heart disease. Am Heart J 1988;116:1708-12.
4. The Guidelines Subcommittee of the WHO/ISH Mild Hypertension Liaison Committee. 1993 guidelines for the management of mild hypertension. Memorandum from a World Health Organization/International Society of Hypertension Meeting. Hypertension 1993;22:392-403.
5. Schräder J, Schoel G, Buhr-Schinner I, et al. Comparison of the antihypertensive efficiency of nitrendipine, metoprolol, mepindolol and enalapril using ambulatory 24-hour blood pressure monitoring. Am J Cardiol 1990;66:967-72.
6. Grandinetti O, Feraco E. Middle term evaluation of amlo-dipine vs nitrendipine: Efficacy, safety and metabolic effects in elderly hypertensive patients. Clin Exp Hypertens 1993; 15:(suppl I): 197-210.
7. Weinberger MH. Angiotensin converting enzyme inhibitors enhance the antihypertensive efficacy of diuretics and blunt or prevent adverse metabolic effects. J Cardiovasc Pharmacol 1989;13(suppl 3):S1-4.
8. Burris JF, Weir MR, Oparil S, Weber M, Cady WJ, Stewart WH. An assessment of diltazem and hydrochlorothiazide in hypertension: Application of factorial trail design to a multicenter clinical trial of combination therapy. JAMA 1994;263:1507-12.
9. Weinberger MH. Blood pressure and metabolic response to hydrochlorothiazide, captopril, and the combination in black and white mild-to-moderate hypertensive patients. J Cardiovasc Pharmacol 1985;7(suppl 1):S52-5.
10. Jones DW, Sands CD. Captopril versus captopril plus hydrochlorothiazide for essential hypertension in Koreans. Am J Cardiol 1991;67:98-9.
11. Vaisse B, Souchet T, Delage Y, Poggi L. Etude comparative de l'énalapril, de I'hydrochlorothiazide et de Ieur association dans le traitement de l'HTA essentielle. Ann Cardiol Angiol 1991;40:51-4.
12. Scholze J, for the East Germany Collaborative Trial Group, et al. Ramipril and hydrocholorothiazide combination therapy in hypertension: A clinical trial of factorial design [Short Report]. J Hypertens 1993;11:217-21.
13. Lang H. The results of a large multicenter study comparing low-dose lisinopril-hydrochlorothiazide with the monocomponents. J Hum Hypertens 1991;5(suppl 2):73-6.
14. Hart W. Lisinopril-hydrochlorothiazide combination compared with the monocomponents in elderly hypertensive patients. J Hum Hypertens 1991;5(suppl 2):85-9.
15. Homuth V, Faulhaber HD, Loose U, Löffler K, Luft FC. Usefulness of piretanide plus ramipril for systemic hypertension: A multicenter trial. Am J Cardiol 1994;72:666-71.
16. Pool JC, Germari J, Goldstein R, et al. Controlled multicenter study of the antihypertensive effects of lisinopril, hydrochlorothiazide and lisinopril plus hydrochlorothiazide in the treatment of 394 patients with mild to moderate essential hypertension. Cardiovasc Pharmacol 1987;9(suppl 3):S36-42.
17. Jones DW, Sands CD. Treatment of essential hypertension in asians: Enalapril as monotherapy versus combination therapy with hydrochlorothiazide. Pharmacotherapy 1991;11:127-30.
18. Staessen J, Fagard R, Lijnen P, Verschueren LJ, Amery A. Double-blind comparison between propranolol and bendro-flumethiazide in captopril-treated resistant hypertensive patients. Am Heart J 1983;106:321-8.
19. Holm S. A simple sequentially rejective multiple test procedure. Scand J Stat 1979;6:65-70.
20. Van Eiteren PH. On the combination of independent two-sample test of Wilcoxon. Bull Int Stat Inst 1960;37:351-61.
21. Todd PA, Benfield P. Ramipril: A review of its pharmacological properties and therapeutic efficacy in cardiovascular disorders. Drug 1990;39:110-35.
22. Clissold SP, Brogden RN. Piretanide: A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy. Drugs 1985;29:489-530.
23. Greger R, Wangemann P. Loop diuretics. Renal Physiol 1987;10:174-83.
24. Dols W, Freude, J, Verho M, Rangoonwala B. A doubleblind study of piretanide in the treatment of hypertension. Curr Med Res Opin 1983;8:649-58.
25. Buckert C, Muhlhauser W, Fratzer U, Verho M. A doubleblind multicenter study of piretanide and hydrochlorothiazide in patients with essential hypertension. J Int Med Res 1984;12:81-6.
26. Weinberger MH. Comparison of captopril and hydrochlorothiazide alone and in combination with mild to moderate essential hypertension. Br J Clin Pharmacol 1982;14:127S-31S.
27. Weinberger MH. Influence of an angiotensin converting-enzyme inhibitor on diuretic induced metabolic effects in hypertension. Hypertension 1983;5:(suppl 3):III132-8.
28. Miller E. Introduction to lisinopril-hydrochlorothiazide combination. J Hum Hypertens 1991;5(suppl 2):49-51.
29. Pathé M. Lisinopril-hydrochlorothiazide combination vs. lisinopril for the treatment of hypertension. J Hum Hypertens 1991; 5(suppl 2):53-4.
30. Bulpitt CJ, Palmer AJ, Fletcher AE, et al. Optimal blood pressure control in treated hypertensive patients. Report from the Department of Health Hypertension Care Computing Project (DHCCP). Circulation 1994;90:225-33.